Customize your JAMA Network experience by selecting one or more topics from the list below.
Incorrect Wording: In the Medical News & Perspectives story entitled “Trials Probe New Agents for Kidney Cancer” published in the July 12, 2006, issue of JAMA (2006;296:155-157), sunitinib was misidentified as a second-line treatment for advanced renal cell carcinoma. On page 155, column 2, the first full sentence should be “The results led to sunitinib's approval by the US Food and Drug Administration in January for advanced renal cell carcinoma.”
Incorrect Wording in: Trials Probe New Agents for Kidney Cancer. JAMA. 2007;297(16):1774. doi:10.1001/jama.297.16.1774